InvestorsHub Logo
Followers 12
Posts 376
Boards Moderated 0
Alias Born 04/24/2012

Re: vonLampertheim post# 6772

Tuesday, 09/06/2016 1:35:19 AM

Tuesday, September 06, 2016 1:35:19 AM

Post# of 41228
My opinion, if there is indeed a difference, then go with the details in the 10-Q.

Below is an interesting example of statements made by a CEO during a conference call. Let me preface that I am in no way attempting to suggest or imply any parallel between this case and Amedica. I am only highlighting an extreme example of discrepancies sometimes found in conference calls. The genesis of this case I believe was due to a FOIA request submitted to the FDA, the results of which were posted on a message board and contradicted what was said by the CEO at an earlier CC.

In all sincerity I hope Amedica achieves the coveted clearance from the FDA for CSC. I have believed in their science from day one and that is what brought in as an investor. Hopefully the quality of their science will translate to investor returns.

http://www.businessinsurance.com/article/20130626/NEWS07/130629879

http://dealbreaker.com/2013/06/medical-device-company-ceo-thought-it-best-not-to-be-100-accurate-with-investors-about-possibly-exploding-device/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News